Patrik Jeanmonod - CHIEF FINANCIAL OFFICER at Cytek Biosciences, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
CTKB on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Patrik Jeanmonod since 31 Aug 2025

Reported holdings for Patrik Jeanmonod in Cytek Biosciences, Inc.

Form 4 holding CHIEF FINANCIAL OFFICER

Cytek Biosciences, Inc.

Security class
Common Stock
Shares / value
97,465
Estimated value
$703,697
Report date
11 Mar 2024
Price
$7.22
Ownership
Direct
Form 4 holding CHIEF FINANCIAL OFFICER

Cytek Biosciences, Inc.

Security class
Restricted Stock Units
Shares / value
44,182
Estimated value
$318,994
Report date
11 Mar 2024
Price
$7.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Patrik Jeanmonod in Cytek Biosciences, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .